Dr. Suryakanta Swain is currently Professor and Dean Research, Associate/Acting Dean, Founder Principal-cum-Head (Pharmacy), School of Health Sciences at The Assam Kaziranga University, Jorhat, Assam, India. He has 14+ years of rich experience with a blend of teaching, research, and administration. He completed B. Pharm Berhampur University and M. Pharm Biju Patnaik University of Technology (B.P.U.T), Odisha, by qualifying National-level exams such as GATE and NIPER. He completed his Ph. D (Pharmacy) from Berhampur University, Odisha. His Doctoral Research work is on the Design and Evaluation of Mucoadhesive Drug Delivery System of Some Selected Drugs (Rabeprazole Sodium and Venlafaxine HCl) to improve oral Bioavailability. Dr. Swain researches QbD enabled mucoadhesive drug delivery systems, self-emulsifying drug delivery systems, gastro-retentive drug delivery systems, and targeted drug delivery systems. Prof. Swain has published 105 Research/Review/Editorial/Opinion Articles of Scopus/SCI/Pubmed/SCI-E/JCR/PCI/UGC-care listed International/National Journals of Publishers such as Springer/Elsevier/Taylor and Francis/Informa Health care/Bentham/Dove Press etc. with highest Journal (Acta Pharmaceutica Sinica B) of Impact factor of 11.413 with more than 1700 Google Scholar citations (H-index=18 and i10-index=34) and 900 Scopus citations (H-index=13), and 27 Research Gate Score (1500 citations). Dr. Swain also Edited 6 National Textbooks as per the New PCI Syllabus of M.Pharm and B.Pharm Courses. He also published 7 International Textbooks and 35 National Book chapters, Received 1 Indian Patent Grant and Published 1 Indian Patent from the Ministry of Commerce, Govt. of India and Patent Innovation already Initiated for Technology Transfer with Pharmaceutical Company and such innovation are also Coverage with Times of India E-News Paper. Prof. Swain has permanent Advisory/Editorial/Reviewer Board Members in more than 100 National/International Journals and Ph.D. Research Supervisors/UG/PG/Pharm-D Practical External Examiners/Ph.D. Adjudicators/Examiner and Members of Board of Studies (Co-Chairman)/Academic Council/IQAC/UDRC/NACC as a Chief School level/NBA coordinator/R & D/External Expert Member of Selection Committee of various Universities such as The Assam Kaziranga University/Acharya Nagarjuna University/JNTU-Kakinada/JNTU-Hyderabad/Annamalai University/Biju Patnaik University of Technology/Berhampur University/GITAM University/Centurion University/Singhania University/AMRI University/SOA University, etc. He is presently guiding 10 Ph.D. Research Scholars and already guided 60+ M. Pharmacy, 40 + B.Pharmacy, and 7 Pharm D 5th year Clinical/Hospital-based projects. Dr. Swain has received several awards, such as Emerging Leader in Health and Medical Sciences Award, Prof. M.L. Khorana Memorial Award, Rajni Bhai V. Patel PharmInnova Competition Award, etc. Dr. Swain has delivered and attended more than 100 AICTE/DST/DBT/PCI/ICMR sponsored at National and International Seminars/Conferences/Workshops/FDPs/SDPs as an Invited Speaker/Resource Person/Guest Lecture/Guest of Honor/Adjudicators etc. He is the life member of several professional bodies such as FIC/APTI/IPA/HAB/IPGA/ISPOR and Members of Reviewer MS Research Australia, Research Management Council, Australia, 2014/Member of Healthcare Advisory Board (HAB), Canada, 2014/ABM International Science and Technology Development INC, Baltimore, USA/Community Member of the Global Community of Information Professionals, Canada 2013/Member of the Pharmacy One Source Community, US 2013/Asian Science Council Editor, Canada/Bentham Science Ambassador/Registered Member of Odisha State Board of Pharmacy Council, 2008/Member of PCI, etc. Dr. Swain is now heading 14 different Programmes and 9 Departments under The Assam Kaziranga University, Jorhat, Assam. He has recently set up six laboratories infrastructure and introduced D and B. Pharmacy new courses and 4 new emerging PG programmes: Master in Optometry, M.Sc. Microbiology, Master in MLT (Medical Microbiology)/MPT (Neurology/Orthopedics), increased 100 intakes of B.Pharm course and designed the new course structures and syllabi for North Eastern Region of India.
<p>The overview of the book includes the Pandemic Corona Virus vs Epidemic, Endemic and Post Pandemic Virus Diseases. For novel coronavirus treatments and prevention guidelines, it suggests allopathic, homeopathic, ayurvedic, home remedy, convalescent plasma therapy, etc. The current global data for the preclinical and clinical status of drugs-approved vaccines and few vaccines under development for coronavirus infections, and the impact of post-COVID-19 on science and technology, current and future directions in academic and industrial research. The primary arena is to explain the health condition and status of post-vaccination that may improve and reduce the long-term effects of the COVID-19 virus. Moreover, briefly enlightened post-COVID-19 recovery patients or vaccination people's worldwide associated side effects, and adverse drug reactions such as Stevens-Johnson syndrome, Toxic epidermal necrolysis, Mucormycosis, White fungus, Yellow fungus, Zika, Delta, Omicron, IHU, and Delmicron viruses are significant blockbusters of this second and third waves of current and post covid situation. The subject matter is written with adequate information about the pandemic, epidemic, endemic, and post-pandemic virus diseases and theoretical background and presented simply for better understanding among the medical, paramedical students, researchers, and scientists across the globe. This book is also handy for budding scientists and pharmaceutical professionals.<br></p>
